Grifols SA is a global specialty plasma therapeutics company that engages in the development, manufacturing, and distribution of a broad range of biological medicines based on plasma-derived proteins. The company is headquartered in Sant Cugat Del Valles, Barcelona and currently employs 23,833 full-time employees. The company went IPO on 2006-05-17. The firm organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.
Grifols SA hisse başına yıllık % {var1} temettüye sahiptir ve % {var2} oranında bir getiri sunmaktadır. Temettü yıllık ödenmektedir ve son temettü hariç tarihi Aug 11, 2025 tarihindedir.
Dividend Yield
Yıllık Dividende
Özsermaye Tarihi
0.00%
$0.18
Aug 11, 2025
Ödeme Sıklığı
Ödeme Oranı
Yıllık
0.00%
Dividend History
Özsermaye Tarihi
Nakit Tutarı
Kayıt Tarihi
Ödeme Tarihi
Aug 11, 2025
$0.15
Aug 12, 2025
Aug 13, 2025
Jun 3, 2021
$0.3643
Jun 4, 2021
Jun 7, 2021
Jun 3, 2021
$0.0102
Jun 4, 2021
Jun 7, 2021
Oct 26, 2020
$0.1616
Oct 27, 2020
Oct 28, 2020
Oct 26, 2020
$0.0101
Oct 27, 2020
Oct 28, 2020
Dec 2, 2019
$0.20
Dec 3, 2019
Dec 4, 2019
Dividend Grafikleri
GIFOF Kâr Payları
GIFOF Dividend Growth (Yıllık Üstünlük)
Follow-Up Questions
Grifols SA'in şu anki temettü ödemesi ve yıllık temettüsü nedir?